Different Acupoints Compatibility Difference of the Effect of Treatment of the Primary Insomnia
NCT ID: NCT02448602
Last Updated: 2015-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
333 participants
INTERVENTIONAL
2015-01-31
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupuncture for Insomnia: a Randomized Controlled Trial
NCT02594670
Acupuncture for the Treatment of Insomnia
NCT00855140
Effects of Acupuncture and Intradermal Acupuncture on Insomnia
NCT01956760
The Study on the Evaluation of Acupuncture Therapy on Primary Insomnia
NCT05830877
Acupuncture for Primary Insomnia
NCT00839592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary insomnia in clinical common disease, frequently-occurring disease, acupuncture curative effect is distinct, disease diagnosis, curative effect evaluation standard. Previous clinical data also show that the primary insomnia is acupuncture clinical diseases. This project by primary insomnia as the research object, research to better guide clinical practice, improve the clinical curative effect, promote acupuncture of the inheritance and innovation, promote scientification of acupuncture and moxibustion, modernization and internationalization, and will have broad prospect of application and significant scientific research value.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single point group (Shenmen)
Patients will be acupuncture with Shenmen(HT7).
acupuncture
Patients will be treated with Shenmen(HT7), needle 1 times a day, 30 min/time, 5 days for a period of treatment, the treatment interval for two days, five intervention treatment, follow-up after 4 weeks.
Sancai coordinated points group
Patients in Sancai coordinated points group, will be acupuncture with Baihui(DU20), Shenmen(HT7), Sanyinjiao(SP6).
acupuncture
Patients in Sancai coordinated points group, will be treated with Baihui(DU20), Shenmen(HT7), Sanyinjiao(SP6), needle 1 times a day, 30 min/time, 5 days for a period of treatment, the treatment interval for two days, five intervention treatment, follow-up after 4 weeks.
Control group
Patients in Control group, will be acupuncture with at the junction of deltoid and biceps.
acupuncture
Patients in Control group, will be treated with at the junction of deltoid and biceps, needle 1 times a day, 30 min/time, 5 days for a period of treatment, the treatment interval for two days, five intervention treatment, follow-up after 4 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acupuncture
Patients will be treated with Shenmen(HT7), needle 1 times a day, 30 min/time, 5 days for a period of treatment, the treatment interval for two days, five intervention treatment, follow-up after 4 weeks.
acupuncture
Patients in Sancai coordinated points group, will be treated with Baihui(DU20), Shenmen(HT7), Sanyinjiao(SP6), needle 1 times a day, 30 min/time, 5 days for a period of treatment, the treatment interval for two days, five intervention treatment, follow-up after 4 weeks.
acupuncture
Patients in Control group, will be treated with at the junction of deltoid and biceps, needle 1 times a day, 30 min/time, 5 days for a period of treatment, the treatment interval for two days, five intervention treatment, follow-up after 4 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-60 (including 18 and 60);
* Does not attend other clinical researchers;
* Participation in the researchers signed informed consent and voluntary;
* Pittsburgh sleep index (PSQI) index \> 7 points;
* Athens scale or 6 points;
* Depression scale and anxiety scale 50 points or less.
* Caused by excessive anxiety and depression of patients with insomnia.
Exclusion Criteria
* Circadian rhythm disorders;
* Sleep disorders;
* Drug-induced insomnia (such as drug abuse, drug treatment);
* Sleep disorders caused by poor diet, lifestyle factors(Long-term excessive drinking, coffee, tea, etc.);
* All systemic diseases (such as pain, fever, cough, surgery, etc.) and the external environment disturbance factors;
* With cardiovascular, lung, liver, kidney and hematopoietic system such as serious primary diseases;
* Patients with mental illness;
* Pregnancy or breast-feeding women;
* Acupoints with severe skin infections;
* Patients who are afraid of acupuncture;
* Advanced malignant tumor or other serious wasting disease, infection and bleeding;
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
OTHER
Hengyang Traditional Chinese Medicine Hospital
OTHER
Second People's Hospital of Hunan
OTHER
Jilin University
OTHER
Qilu Hospital of Shandong University
OTHER
Changchun University of Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tie Li
973 project management deputy director of the office
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fuchun Wang, master
Role: STUDY_CHAIR
Dean
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Affiliated Hospital To Changchun University of Chinese Medicine
Changchun, Jilin, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Ha L, Liu X, Liu Y, Zhi M, Jiang H, Zhao J, Wang Y, Xu X, Guo L, Cao J, Chen L, Yuan Y, Li T, Wang F. Scheme optimization of acupoints compatibility and influence factors of the effect. Medicine (Baltimore). 2021 Dec 17;100(50):e27883. doi: 10.1097/MD.0000000000027883.
Shi XH, Wang YK, Li T, Liu HY, Wang XT, Wang ZH, Mang J, Xu ZX. Gender-related difference in altered fractional amplitude of low-frequency fluctuations after electroacupuncture on primary insomnia patients: A resting-state fMRI study. Brain Behav. 2021 Jan;11(1):e01927. doi: 10.1002/brb3.1927. Epub 2020 Nov 4.
Wang YK, Li T, Ha LJ, Lv ZW, Wang FC, Wang ZH, Mang J, Xu ZX. Effectiveness and cerebral responses of multi-points acupuncture for primary insomnia: a preliminary randomized clinical trial and fMRI study. BMC Complement Med Ther. 2020 Aug 17;20(1):254. doi: 10.1186/s12906-020-02969-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ChangchunUCM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.